New York, NY (PRWEB) June 22, 2013
The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those patients taking the medications Januvia or Janumet. A federal panel will meet next week to decide which court venue will handle growing lawsuits alleging the drugs caused cancer*.
The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs like Januvia and Janumet by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Januvia and Janumet are pill-form diabetes medications prescribed to help those with type-2 diabetes control blood sugar. The drugs were two of the best-selling for Merck in recent years, with sales of over $4 billion last year**.
The resource center contains studies suggesting Januvia and Janumet may be linked to cancer. A 2011 study from UCLA indicated the drug could increase the risk of pancreatic cancer by 172% and thyroid cancer by 48%***. The FDA is also investigating the risk of Janumet and Januvia cancer after receiving reports that some patients who died showed signs of early pancreatic cancer cells****.
DrugRisk also added a report by Dr. Peter Butler, head of endocrinology at UCLA, warning that the Januvia pancreatic cancer risk was not detected in trials prior to FDA approval because the manufacturer used very young animals not as prone to pancreatic cancer*****.
Now, with 53 patients having already filed a Januvia lawsuit alleging cancer, the Judicial Panel on Multidistrict Litigation will meet on July 25th to determine where to consolidate the growing number of cases*. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).
Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.
For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*JPML, 6/12/13; jpml.uscourts.gov/sites/jpml/files/Hearing_Order-7-25-13.pdf
**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
****FDA, 3/14/13; http://www.fda.gov/Drugs/DrugSafety/ucm343187.htm
*****New York Times, 5/31/13; nytimes.com/2013/05/31/business/a-doctor-raises-questions-about-a-diabetes-drug.html?hp&_r=1&
Read the full story at http://www.prweb.com/releases/januvia-lawsuit/pancreatic-thyroid-cancer/prweb10859222.htm.
Copyright©2012 Vocus, Inc.
All rights reserved